secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2023-02-03T23:59:59+00:00
Accession:  0001140361-23-004345
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano guides FY2022 revenue $27.7-28M; updates TAM to $10B
------------------------------------------------------------

- FY2022 revenue expected $27.7M-$28.0M; breakdown: 57% systems/consumables, 21% software, 22% services.
- Geographic revenue: Americas 50%, APAC 17%, EMEA 33%.
- TAM estimated at $10B annually, with $3B from cell bioprocessing QC opportunity.
- Target markets include 10,000 labs and 1,400 therapeutics companies for OGM adoption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123004345/0001140361-23-004345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123004345/brhc10047533_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-004345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer